Digene Corporation Product Pipeline Analysis

Publication Date	May 2008
Publisher	Global Markets Direct
Product Type	Report
Pages	37
ISBN Number	not applicable
Product Code	GMD04891

Price

£505.00
approximately: $750 | €594

PDF

Order above formats by FAX

Summary

This report is an insightful source for data, analysis and strategic insights into a Digene Corporation's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

Details of development stage by sector and equipment type.
Pipeline products grouped by therapy area, development stage and trial phase.
Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
Product updates covering estimated approval dates and estimated launch dates.
Descriptions of novel technologies relating to pipeline products of the company.
Patents and patent applications covered for the product.
News updates on key events relating to the product and its development.

Reason to buy

A single source to fulfill competitor information relating to products in development.
Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

Access clinical trial information to map trial results and plan targeted marketing activities.
Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
Identification of potential investment opportunities.
Build up knowledge base for potential distribution and marketing partners.
Helps avoid patent infringement.
Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content

1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
2 Company Snapshot
- 2.1 Key Information
- 2.2 Company Overview
- 2.3 Financial Performance
- 2.4 Industry Outlook - In Vitro Diagnostics
3 Digene Corporation Pipeline Products
- 3.1 Digene Corporation Product Pipeline Analysis
  - 3.1.1 Digene Corporation Pipeline Products By Equipment Type
  - 3.1.2 Digene Corporation Pipeline Products By Development Stage
  - 3.1.3 Digene Corporation Pipeline Products By Therapy Area
  - 3.1.4 Digene Corporation Pipeline Products By News Summary
- 3.2 Customized HPV test
  - 3.2.1 Product Description
  - 3.2.2 Product Status
  - 3.2.3 Product Milestone
- 3.3 Next generation cystic fibrosis test
  - 3.3.1 Product Description
  - 3.3.2 Product Status
  - 3.3.3 Product Milestone
- 3.4 Multiplex instrument
  - 3.4.1 Product Description
  - 3.4.2 Product Status
  - 3.4.3 Product Milestone
4 Business Description
- 4.1 Business Overview
- 4.2 Major Products and Services
  - 4.2.1 Overview
5 Competitors
6 Key Employees
7 Key Employee Biographies
8 Company Statement
9 Locations And Subsidiaries
- 9.1 Head Office
- 9.2 Other Locations & Subsidiaries
10 Financial Deals Landscape
- 10.1 Acquisition
  - 10.1.1 QIAGEN Acquires Digene
- 10.2 IPO
  - 10.2.1 Digene Completes Common Stock Offering
- 10.3 Partnership
  - 10.3.1 Digene Enters Into An Agreement With Asuragen
11 Recent Developments
- 11.1 Product Announcements
  - 11.1.1 Oct 18, 2007 HPV Test More Accurate Than Pap Smear In Detecting Cervical Cancer
  - 11.1.2 May 11, 2007 Digene Research at Clinical Virology Symposium Shows Strides in Multiplex Genotyping Technology Development
  - 11.1.3 Apr 19, 2007 Digene Announces Exclusive Marketing and Distribution Agreement with Asuragen, Inc. for Signature Cystic Fibrosis Screening Products
  - 11.1.4 Mar 08, 2007 Detecting High-Risk HPV in Older Women
  - 11.1.5 Dec 19, 2007: QIAGEN, Ventana Announce Settlement Of Patent Dispute
- 11.2 Financial Announcements
  - 11.2.1 May 08, 2007: Digene Reports Q3 Fiscal 2007 Results
  - 11.2.2 Feb 01, 2007: Digene Reports Q2 Fiscal 2007 Results
  - 11.2.3 Nov 02, 2006: Digene Reports Q1 Fiscal 2007 Results
  - 11.2.4 Aug 08, 2006: Digene Reports Fiscal Year-End 2006 Results
- 11.3 Other Significant Developments
  - 11.3.1 Nov 14, 2006: Digene Appoints New CEO And Director
  - 11.3.2 Aug 23, 2006: Digene President, COO and CFO Resigns
12 Appendix
- 12.1 Methodology
  - 12.1.1 Coverage
  - 12.1.2 Secondary Research
  - 12.1.3 Primary Research
  - 12.1.4 Expert Panel Validation
- 12.2 Contact Us
- 12.3 About Global Markets Direct
- 12.4 Disclaimer
List of Tables
- Table 1: Digene Corporation,Key Facts
- Table 2: Digene Corporation Pipeline Products by Equipment Type
- Table 3: Digene Corporation Pipeline Products By Development Stage
- Table 4: Digene Corporation Pipeline Products By Therapy Area
- Table 5: Digene Corporation Pipeline Products By News Summaries
- Table 6: Digene Corporation, Key Employees,
- Table 7: Digene Corporation, Subsidiaries
List of Figures
- Figure 1: Digene Corporation Pipeline Products By News Summary
- Figure 2: Global Markets Direct Methodology